Condition: Mitral Valve Regurgitation · Sponsor: Shanghai NewMed Medical Co., Ltd.
To evaluate the safety and performance of the Mi-thos® Mitral Heart Valve with the Mi-thos® Transcatheter Delivery System.
This description comes directly from the study's public registry record.
Wang chunyang, CRA · (86)-21-20788668 · cywang@newmed.cn
Xie xuyang, c · (86)-21-20788668 · xyxie@newmed.cn
Always discuss trial participation with your own doctor first.
| Fuwai hospital | Beijing, Beijing Municipality, China | Recruiting |
| Zhongshan Hospital | Shanghai, Shanghai Municipality, China | Recruiting |
| Xijing hospital | Xi’an, Shanxi, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04195984